Rankings
▼
Calendar
EVAX FY 2019 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena
EVAX
Evaxion Biotech A/S
$23M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$80,984
Operating Income
-$11M
Net Income
-$11M
EPS (Diluted)
$-27.60
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$11M
Total Liabilities
$2M
Stockholders' Equity
$9M
Cash & Equivalents
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$80,984
-$73,928
-9.5%
Operating Income
-$11M
-$6M
-101.9%
Net Income
-$11M
-$6M
-102.2%
← FY 2018
All Quarters
Q4 2019 →